Galanin peptide family regulation of glucose metabolism
P Fang, M Yu, M Shi, P Bo, Z Zhang - Frontiers in Neuroendocrinology, 2020 - Elsevier
Recent preclinical and clinical studies have indicated that the galanin peptide family may
regulate glucose metabolism and alleviate insulin resistance, which diminishes the …
regulate glucose metabolism and alleviate insulin resistance, which diminishes the …
Cardioprotective effects of neuropeptide galanin: Focusing on its roles against diabetic heart
Y She, R Ge, X Gu, P Fang, Z Zhang - Peptides, 2023 - Elsevier
Following an unprecedented rise in the number of the aged, the incidence of age-related
diseases, such as diabetes and cardiovascular disease, is consequently increasing in the …
diseases, such as diabetes and cardiovascular disease, is consequently increasing in the …
[HTML][HTML] Alleviation of Limosilactobacillus reuteri in polycystic ovary syndrome protects against circadian dysrhythmia-induced dyslipidemia via capric acid and …
Abstract Knowledge gaps that limit the development of therapies for polycystic ovary
syndrome (PCOS) concern various environmental factors that impact clinical characteristics …
syndrome (PCOS) concern various environmental factors that impact clinical characteristics …
[HTML][HTML] Treatment with celastrol protects against obesity through suppression of galanin-induced fat intake and activation of PGC-1α/GLUT4 axis-mediated glucose …
P Fang, B He, M Yu, M Shi, Y Zhu, Z Zhang… - Biochimica et Biophysica …, 2019 - Elsevier
Overweight and obesity may cause several metabolic complications, including type 2
diabetes mellitus and hyperlipidemia. Despite years of progress in medicine, there are no …
diabetes mellitus and hyperlipidemia. Despite years of progress in medicine, there are no …
[HTML][HTML] Serum nesfatin-1 and galanin concentrations in the adult with metabolic syndrome: relationships to insulin resistance and obesity
MN Alotibi, AM Alnoury, AM Alhozali - Saudi medical journal, 2019 - ncbi.nlm.nih.gov
Objectives: To investigate the serum levels of nesfatin-1 and galanin in patients with
metabolic syndrome (MetS), and also to show their association with the parameters of the …
metabolic syndrome (MetS), and also to show their association with the parameters of the …
Neuropeptide modulation of addiction: Focus on galanin
SG Genders, KJ Scheller, E Djouma - Neuroscience & Biobehavioral …, 2020 - Elsevier
Addiction is a chronic, relapsing disorder characterised by the use of a substance or act to
the point of compulsion. There are a number of medical treatments available for the …
the point of compulsion. There are a number of medical treatments available for the …
Emerging roles of kisspeptin/galanin in age-related metabolic disease
P Fang, Y She, J Zhao, J Yan, X Yu, Y Jin, Q Wei… - Mechanisms of Ageing …, 2021 - Elsevier
Age is a major risk factor for developing metabolic diseases such as obesity and diabetes.
There is an unprecedented rise in obesity and type 2 diabetes in recent decades. A …
There is an unprecedented rise in obesity and type 2 diabetes in recent decades. A …
Positive correlation of galanin with insulin resistance and triglyceride levels in obesechildren
Background/aim: Galanin is a neuropeptide that is shown to be involved in the regulation of
food intake and glucose homeostasis. The objective of this study was to evaluate the relation …
food intake and glucose homeostasis. The objective of this study was to evaluate the relation …
A promising biomarker of elevated galanin level in hypothalamus for osteoporosis risk in type 2 diabetes mellitus
P Fang, Y She, L Han, S Wan, W Shang… - Mechanisms of Ageing …, 2021 - Elsevier
Type 2 diabetes mellitus (T2DM) and osteoporosis are two major healthcare problems
worldwide. T2DM is considered to be a risk factor for osteoporosis. Interestingly, several …
worldwide. T2DM is considered to be a risk factor for osteoporosis. Interestingly, several …
Regulatory effects of galanin system on development of several age-related chronic diseases
P Fang, M Yu, D Wan, L Zhang, L Han, Z Shen… - Experimental …, 2017 - Elsevier
Age is a major risk factor for developing chronic diseases, including type 2 diabetes,
depression and Alzheimer's disease. The rapidly increase in the morbidity of these age …
depression and Alzheimer's disease. The rapidly increase in the morbidity of these age …